The slide to be stained for
CK-Pan comprised:
1. Liver, 2. Esophagus, 3. Renal cell carcinoma, 4. Lung
adenocarcinoma, 5. Small cell lung
carcinoma
All tissues were fixed in 10% neutral buffered formalin.
Criteria for assessing a CK-Pan staining as optimal included:
- A strong, distinct cytoplasmic reaction
of virtually all the bile ductal epithelial cells, and at least
a moderate cytoplasmic reaction with membrane accentuation of the large
majority of hepatocytes.
- A strong, distinct cytoplasmic reaction
of the squamous epithelial cells throughout all cell layers in
the esophagus (a weak reaction in the basal cells was
accepted with the mAb clone KL1).
- A strong, distinct cytoplasmic reaction
in the majority of the neoplastic cells of the lung
adenocarcinomas.
- An at least moderate, distinct
cytoplasmic reaction in the majority of the neoplastic cells of
the renal cell carcinoma and the lung small cell carcinoma.
168 laboratories participated in this
assessment. 65 % achieved a sufficient mark. In table 1 the
antibodies (Abs) used and marks are summarized.
Table 1.
Abs and
assessment marks
for CK-PAN, run 30
|
Concentrated Abs |
N |
Vendor |
Optimal |
Good |
Borderl. |
Poor |
Suff.1 |
Suff. OPS2 |
mAb clone cocktail
AE1/AE3 |
62
10
6
3
2
1
1
1
1 |
Dako
NeoMarkers
Leica/Novocastra
BioGenex
Millipore
BioCare
ID labs
Monosan
Zytomed |
34 |
29 |
18 |
6 |
72 % |
85 % |
|
mAb clone MNF116 |
14 |
Dako |
0 |
4 |
4 |
6 |
29 % |
- |
|
mAb clone KL1 |
7
1 |
Beckman Coulter
AbD-Serotec |
1 |
5 |
2 |
0 |
75 % |
100 % |
mAb clone cocktail
AE1/AE3/5D3 |
4 |
BioCare |
2 |
2 |
0 |
0 |
- |
- |
mAb clone cocktail
5D3/LP34 |
1
1 |
Master Diagostica
Monosan |
0 |
1 |
0 |
1 |
- |
- |
mAb clone cocktail
MNF116/DC10/
AE1AE3/CAM5.2 |
1 |
Dako/BD
(home-made cocktail) |
1 |
0 |
0 |
0 |
- |
- |
|
mAb clone Lu-5 |
2
1 |
NeoMarkers
BMA Biomedicals |
0 |
0 |
2 |
1 |
- |
- |
|
mAb clone C-11 |
1
1 |
Neomarkers
Leica/Novocastra |
0 |
1 |
1 |
0 |
- |
- |
mAb clone cocktail
PAN CK Ab-2 |
2 |
NeoMarkers |
0 |
0 |
0 |
2 |
- |
- |
mAb clone cocktail
MNF116/LP34 |
1 |
Dako/Monosan
(home-made cocktail) |
0 |
0 |
0 |
1 |
- |
- |
|
pAb Z0622 |
2 |
Dako |
0 |
0 |
1 |
1 |
- |
- |
|
Ready-To-Use Abs |
|
|
|
|
|
|
|
|
mAb clone cocktail
AE1/AE3/PCK26,
760-2595 & 760-2135 |
19 |
Ventana |
8 |
4 |
6 |
1 |
63 % |
100 % |
|
mAb, clone cocktail AE1/AE3 IR053 |
14 |
Dako |
11 |
2 |
0 |
1 |
93 % |
100 % |
|
mAb, clone cocktail AE1/AE3, 313M-18 |
2 |
Cell Marque |
1 |
1 |
0 |
0 |
- |
- |
|
mAb, clone cocktail AE1/AE3, PA0909 |
2 |
Leica/Novocastra |
0 |
0 |
2 |
0 |
- |
- |
|
mAb clone cocktail AE1/AE3 PM011 |
1 |
BioCare |
0 |
1 |
0 |
0 |
- |
- |
|
mAb clone cocktail AE1/AE3 E006 |
1 |
Linaris |
0 |
0 |
1 |
0 |
- |
- |
|
mAb clone cocktail AE1/AE3+Ks13.2 E020 |
1 |
Linaris |
0 |
0 |
1 |
0 |
- |
- |
|
mAb clone cocktail AE1/AE3+5D3 PM162 |
1 |
BioCare |
0 |
0 |
1 |
0 |
- |
- |
|
mAb clone
MNF116, N1523 |
1 |
Dako |
0 |
0 |
0 |
1 |
- |
- |
|
Total |
168 |
|
58 |
50 |
39 |
21 |
- |
- |
|
Proportion |
|
|
35 % |
30 % |
23 % |
12 % |
65 % |
- |
1) Proportion of sufficient stains
(optimal or good), 2) Proportion of sufficient stains with optimal
protocol settings only, see below.
Following central protocol parameters were used to obtain an optimal
staining:
Concentrated Abs
mAb clone cocktail AE1/AE3: The protocols giving an optimal
result were all based on heat induced epitope retrieval (HIER) using
either Tris-EDTA/EGTA pH 9 (9/18)*, Target Retrieval Solution (TRS)
pH 9 (Dako) (5/9), TRS pH 9 (3-in-1,Dako) (4/9), Cell Conditioning 1
(BenchMark, Ventana) (8/26), Bond Epitope Retrieval Solution 1
(Bond, Leica) (1/2), Diva Decloaker (Biocare) (2/3), EDTA/EGTA pH8
(1/1) or Citrate pH 6 (4/10) as the retrieval buffer. The mAb was
typically diluted in the range of 1:50– 1:200 depending on the total
sensitivity of the protocol employed. Using these protocol settings
56 out of 66 (85 %) laboratories produced a sufficient staining
(optimal or good).
* (number of optimal results/number of laboratories using this
buffer)
mAb clone cocktail AE1/AE3/5D3: The protocols giving an
optimal result were all based on HIER using either Tris-EDTA/EGTA pH
9 (1/1) or TRS pH 9 (3-in-1, Dako) (1/1) as the retrieval buffer. The
mAb was typically diluted in the range of 1:200– 1:400 depending on
the total sensitivity of the protocol employed. Using these protocol
settings both of 2 laboratories produced a sufficient
staining (optimal or good).
mAb clone “home-made” cocktail MNF116/DC10/AE1AE3/CAM5.2: The
protocol giving an optimal result was based on HIER using Cell
Conditioning 1 (BenchMark, Ventana) (1/1) as the retrieval buffer.
The dilutions of the mAbs is unknown.
mAb clone KL1: The protocol giving an optimal result was
based on HIER using TRS pH 9 (3-in-1, Dako) (1/3) as the retrieval
buffer. The mAb was diluted 1:20.
Ready-To-Use Abs
mAb clone cocktail AE1/AE3/PCK26 (prod. no. 760-2595 &
760-2135, Ventana): The protocols giving an optimal result were
based on a combined proteolysis and HIER using Protease 3 for 4 min
and mild Cell Conditioning 1, an incubation time of 8-32 min in the
primary Ab and UltraView (760-500) as the detection system. 1 lab
used amplification. Using these protocol settings 9 out of 9 (100 %)
laboratories produced a sufficient staining (optimal or good).
mAb, clone cocktail AE1/AE3 (prod. no. IR053, Dako): The
protocols giving an optimal result were all based on HIER in PT-Link
using TRS pH 9 or TRS pH 9 (3-in-1) and an incubation time of 10-30
min in the primary Ab and EnVision Flex (K8000) or Flex+ (K8002) as
the detection system. Using these protocol settings 12 out of 12
(100 %) laboratories produced a sufficient staining (optimal or
good).
1 laboratory used HIER in standard Cell Conditioning 1 (Benchmark,
Ventana), an incubation time of 32 min. in the primary Ab and
UltraView (760-500) as the detection system.
mAb, clone cocktail AE1/AE3 (prod. no. 313M-18, Cell Marque):
The protocol giving an optimal result was based on HIER using Bond
Epitope Retrieval Solution 2 (Bond, Leica) and an incubation time of
15 min in the primary Ab and BOND Polymer Refine Detection (DS9800)
as the detection system. Using this protocol setting 1 out of 1
laboratory produced an optimal staining.
- - -
The most frequent causes of insufficient staining reactions were:
- Inappropriate epitope retrieval (e.g., proteolysis for the mAb
clone AE1/AE3)
- Too low concentration of the primary antibody
- Less successful primary Ab.
In this assessment and in concordance with the previous CK-Pan
assessments in NordiQC the prevalent feature of an insufficient
staining was a too weak or false negative reaction of the cells and
structures expected to be demonstrated. The majority of the
laboratories were able to demonstrate CK in the columnar epithelial
cells of the bile ducts, the neoplastic cells of the lung
adenocarcinoma and the lung small cell carcinoma. However, the
demonstration of CK in the neoplastic cells of the renal cell
carcinoma and the hepatocytes was more difficult and only seen for
protocols with a high sensitivity and appropriate protocol settings,
e.g. as obtained with a correct titre of the mAb clone cocktails
AE1/AE3 and AE1/AE3/5D3 combined with efficient HIER. This is
illustrated in table 2 where the cumulated data for the most widely
used clones in the last four assessments for CK-Pan is listed
relating the pass rate for the clone to the epitope retrieval
method. E.g. the over-all pass rate for AE1/AE3 was 69%, but 74%
when HIER was applied and 12% when protease was used.
Table 2: Cumulated data for selected CK-PAN clones
|
Pass rates for run 15, 20, 24 & 30 |
|
|
Total |
HIER |
Proteolysis |
HIER + proteolysis |
|
|
Protocols |
Sufficient |
Protocols |
Sufficient |
Protocols |
Sufficient |
Protocols |
Sufficient |
|
MAb AE1/AE3 |
294 |
203 (69%) |
269 |
200 (74%) |
25 |
3 (12%) |
0 |
- |
|
MAb MNF116 |
53 |
25 (46%) |
31 |
7 (23%) |
30 |
18 (60%) |
2 |
2 (100%) |
|
MAb KL1 |
33 |
21 (64%) |
33 |
21 (64%) |
0 |
0 |
0 |
- |
|
MAb AE1/AE3/PCK26 |
39 |
12 (31%) |
6 |
1 (17%) |
20 |
0 |
13 |
12 (92%) |
|
MAb AE1/AE3/5D3 |
16 |
15 (94%) |
15 |
15 (100%) |
1 |
0 |
0 |
- |
|
MAb Ab2 |
10 |
6 (60%) |
5 |
4 (80%) |
5 |
2 (40%) |
0 |
- |
|
MAb 5D3/LP34 |
8 |
2 (25%) |
7 |
2 (29%) |
1 |
0 |
0 |
- |
From this table is seems that the most robust marker for CK-Pan is
the mAb clone cocktail AE1/AE3/5D3 used with HIER as all of 15
protocols based on this combination resulted in a sufficient
staining result.
For the mAb cocktail AE1/AE3/PCK26 (Ready-To-Use format Ventana)
12/13 protocols (92%) based on a combined epitope retrieval of
proteolysis and HIER gave a sufficient staining result (whereas 0/20
protocols based on proteolysis gave a sufficient staining result,
all false negative). If HIER was performed as single pre-treatment an
aberrant strong cytoplasmic staining reaction in virtually all
smooth muscle cells was seen. Applying the combined pre-treatment
using proteolysis and HIER, the staining reaction in the smooth
muscle cells was significantly reduced and still giving an optimal
result similar to the result obtained by using AE1/AE3, AE1/AE3/5D3
and KL1 with HIER.
As seen in the previous assessments of CK-Pan, liver and esophagus
combined is recommendable as positive controls for CK-Pan: It is crucial that the majority of the hepatocytes
(expressing only a limited amount of the primary low molecular
weight CK types 8 and 18) show at least a moderate staining reaction. In the esophagus virtually all the squamous epithelial cells expressing the high molecular weight
cytokeratins must show at least a moderate distinct cytoplasmic
staining. In this context it has to be emphasized that the mAb
clone KL1 only has a weak affinity for the primary high molecular
weight CK types 5 & 14, which is expressed in the basal squamous
epithelial cells and thus only show a weak staining even in
protocols giving an otherwise optimal staining using the mAb clone
KL1. Due to the weak staining reaction of the basal squamous
epithelial cells in the esophagus, the Merkel cells was easily
recognized using the mAb clone KL1 as these cells showed a strong
cytoplasmic staining due to the CK types CK8, 18 and 19.
This was the 5th assessment of CK-Pan in NordiQC, and a slight but
constant increase in the proportion of sufficient results has been
obtained as as shown in table 3:
Table 3:
Proportion of sufficient results for CK-PAN in the five NordiQC runs
performed
Conclusion
The mAb clone cocktails AE1/AE3, AE1/AE3/5D3 and AE1/AE3/PCK26,
and mAb clone KL1 can all be used to obtain an optimal staining for
CK-Pan. The epitope retrieval and protocol settings have to be
specifically tailored to each of the clones/cocktails. Liver and
esophagus combined are appropriate control tissues irrespective of the
clone/cocktail applied: Almost all hepatocytes must show a distinct
cytoplasmic staining with membrane enhancement,
while virtually all the squamous epithelial cells of the esophagus must
show at least a moderate cytoplasmic staining. |